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Abstract
Objective: To evaluate the maternal and perinatal outcomes of 
pregnancies delivered at 23+0 to 23+6 weeks’ gestation .
Methods: This prospective cohort study included women in the 
Canadian Perinatal Network who were admitted to one of 16 
Canadian tertiary perinatal units between August 1, 2005, and 
March 31, 2011, and who delivered at 23+0 to 23+6 weeks’ 
gestation . Women were included in the network if they were 
admitted with spontaneous preterm labour with contractions,  
a short cervix without contractions, prolapsing membranes with 
membranes at or beyond the external os or a dilated cervix, 
preterm premature rupture of membranes, intrauterine growth 
restriction, gestational hypertension, or antepartum hemorrhage . 
Maternal outcomes included Caesarean section, placental 
abruption, and serious complication . Perinatal outcomes were 
mortality and serious morbidity .
Results: A total of 248 women and 287 infants were included in 
the study . The rate of Caesarean section was 10 .5% (26/248) 
and 40 .3% of women (100/248) had a serious complication, the 
most common being chorioamnionitis (38 .6%), followed by blood 
transfusion (4 .5%) . Of infants with known outcomes, perinatal 
mortality was 89 .9% (223/248) (stillbirth 23 .3% [67/287] and 
neonatal death 62 .9% [156/248]) . Of live born neonates with 
known outcomes (n = 181), 38 .1% (69/181) were admitted to 
NICU . Of those admitted to NICU, neonatal death occurred in 
63 .8% (44/69) . Among survivors at discharge, the rate of severe 
brain injury was 44 .0% (11/25), of retinopathy of prematurity 
58 .3% (14/24), and of any serious neonatal morbidity 100% 
(25/25) . Two subgroup analyses were performed: in one, 
antepartum stillbirths were excluded, and in the other only centres 
that indicated they offered fetal monitoring at 23 weeks’ gestation 
were included and antepartum stillbirths were excluded . In each of 
these, perinatal outcomes similar to the overall group were found .
Conclusion: Pregnant women delivering at 23 weeks’ gestation 
are at risk of morbidity . Their infants have high rates of serious 
morbidity and mortality . Further research is needed to identify 
strategies and forms of management that not only increase 
perinatal survival but also reduce morbidities in these extremely 
low gestational age infants and reduce maternal morbidity .
Résumé
Objectif : Évaluer les issues maternelles et périnatales des 
grossesses donnant lieu à un accouchement entre 23+0 et 
23+6 semaines de gestation .
Méthodes : Cette étude de cohorte prospective portait sur des 
femmes du Réseau périnatal canadien qui ont été admises à l’une 
des 16 unités périnatales tertiaires canadiennes participantes 
entre le 1er août 2005 et le 31 mars 2011, et qui ont accouché 
entre 23+0 et 23+6 semaines de gestation . Les femmes ont 
été admises dans le réseau si elles avaient été hospitalisées 
en raison d’un travail préterme spontané (s’accompagnant de 
contractions), d’un col court (sans contractions), d’un prolapsus 
des membranes (s’accompagnant d’une dilatation du col ou 
dans le cadre duquel les membranes se situaient au niveau de 
l’orifice externe ou faisaient saillie au-delà de ce dernier), d’une 
rupture prématurée des membranes préterme, d’un retard de 
croissance intra-utérin, d’une hypertension gestationnelle ou d’une 
hémorragie antepartum . Parmi les issues maternelles, on trouvait 
la césarienne, le décollement placentaire et la manifestation d’une 
complication grave . La morbidité grave et la mortalité constituaient 
les issues périnatales .
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Résultats : En tout, 248 femmes et 287 nouveau-nés ont été inclus 
dans l’étude . Le taux de césarienne était de 10,5 % (26/248) 
et 40,3 % des femmes (100/248) ont connu une complication 
grave (la plus courante étant la chorioamnionite [38,6 %], suivie 
de la transfusion sanguine [4,5 %]) . Parmi les nouveau-nés 
pour lesquels les issues étaient connues, le taux de mortalité 
périnatale était de 89,9 % (223/248) (taux de mortinaissance : 
23,3 % [67/287] et taux de décès néonatal : 62,9 % [156/248]) . 
Une admission à l’UNSI a été requise pour 38,1 % (69/181) des 
enfants nés vivants pour lesquels les issues étaient connues  
(n = 181) . Parmi ces enfants ayant dû être admis à l’UNSI, un 
décès néonatal a été constaté dans 63,8 % (44/69) des cas . 
Chez les survivants (au moment de l’obtention de leur congé de 
l’UNSI), le taux de lésion cérébrale grave était de 44,0 % (11/25), 
le taux de rétinopathie des prématurés était de 58,3 % (14/24) et 
le taux de quelque morbidité néonatale grave que ce soit était de 
100 % (25/25) . Deux analyses de sous-groupe ont été menées : 
dans le cadre de l’une d’entre elles, les mortinaissances pendant 
la période antepartum ont été exclues; dans le cadre de l’autre, 
seuls les centres ayant indiqué qu’ils offraient le monitorage fœtal 
à 23 semaines de gestation ont été inclus et les mortinaissances 
pendant la période antepartum ont également été exclues . Des 
issues périnatales semblables à celles du groupe général ont été 
constatées dans chacune de ces analyses .
Conclusion : Les femmes enceintes qui accouchent à 23 semaines 
de gestation sont exposées à des risques de morbidité . Leurs 
nouveau-nés présentent des taux élevés de morbidité grave et 
de mortalité . La poursuite de la recherche s’avère requise pour 
permettre l’identification de stratégies et de formes de prise en 
charge qui entraînent non seulement une amélioration du taux 
de survie périnatale, mais également une baisse des taux de 
morbidité que connaissent ces nouveau-nés d’âge gestationnel 
extrêmement faible et les mères .
J Obstet Gynaecol Can 2015;37(3):214–224
INTRODUCTION
In Canada, preterm birth (less than 37 weeks’ gestation) complicates 7.9 % of  pregnancies, with 1.2% of  all 
births occurring at less than 32 weeks’ gestation.1 Preterm 
birth can result  in significant perinatal morbidity, both in 
the short term and long term, particularly in infants born 
at earlier gestational ages.1–5 Multiple studies have evaluated 
perinatal outcomes of  infants born in the periviable 
period (23 weeks’ gestation).3–39 Many of  these studies, 
however, have excluded infants that were stillborn or that 
died before admission to NICU.3,4,15,21–24,27,34 In addition, 
some studies present data based on birth weight and not 
gestational age.29,40–44 Finally, a number of  studies present 
data from populations that may differ from the Canadian 
population with respect to ethnicity and access to health 
care.3,7–14,16–23,34,45 Few studies have evaluated maternal 
outcomes of  women delivering at a periviable gestation.
It is important to consider maternal and perinatal 
outcomes, including stillbirth and neonatal death before 
NICU admission, when counselling and planning 
management of  women admitted at 23 weeks’ gestation 
with risk of  preterm delivery. The objective of  this study 
was to summarize the maternal and perinatal outcomes 
of  pregnancies delivered at 23 weeks’ gestation in tertiary 
perinatal care centres in Canada.
METHODS
The details of  the Canadian Perinatal Network (CPN) have 
been published previously.46 The mandate of  the CPN is 
to focus on the maternal and perinatal outcomes and the 
optimal management of  threatened very preterm birth 
at 22+0 weeks to 28+6 weeks of  gestation. The CPN 
includes admissions to 16 of  23 tertiary perinatal units 
across Canada from August 1, 2005, to March 31, 2011.
Inclusion criteria for the CPN were women admitted 
between 22+0 weeks and 28+6 weeks of  gestation 
inclusive to a participating tertiary perinatal unit, between 
August 1, 2005, and March 31, 2011, with at least one of  
the following indications: spontaneous preterm labour with 
contractions,  short  cervix  without  contractions  (defined 
as a cervical length < 2.0 cm on endovaginal ultrasound 
without regular contractions), prolapsing membranes with 
membranes at or beyond the external os, or any cervical 
dilatation (on endovaginal ultrasound examination) without 
regular contractions, preterm premature rupture of  
membranes, intrauterine growth restriction (less than the 
10th centile for gestational age), gestational hypertension 
(systolic  blood  pressure ≥ 140 mmHg or  diastolic  blood 
pressure ≥ 90 mmHg  on  two  occasions  at  least  4  hours 
apart after 20 weeks), or antepartum hemorrhage (> 15 mL 
of  vaginal bleeding before the onset of  labour). In this 
study we included women who delivered at 23+0 weeks to 
23+6 weeks’ gestation. Dating of  the pregnancy was based 
on the clinician’s best estimate using a combination of  last 
menstrual period and ultrasound.
Data collected included maternal demographic factors (age, 
parity, weight, BMI, ethnicity, and socioeconomic status as 
determined by census enumerator data of  neighbourhood 
income levels). Other maternal data included past 
obstetric, medical, and surgical history; aspects of  the 
current pregnancy including the indication for enrolment 
in the CPN (preterm labour, prolapsing membranes, 
short cervix, growth restriction, antepartum hemorrhage, 
gestational hypertension), smoking, alcohol use, and illicit 
drug use during pregnancy; and interventions used during 
the pregnancy (including antibiotics, corticosteroids, 
tocolytics, and cervical cerclage). Other information 
regarding admission included gestational age at enrolment 
in CPN (admission), gestational age at delivery, latency 
from admission to delivery, route of  delivery, and perinatal 
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morbidity and mortality including stillbirth, neonatal death, 
birth weight, NICU admission, and serious morbidities 
(bronchopulmonary dysplasia, retinopathy of  prematurity, 
severe brain injury, necrotizing enterocolitis, and sepsis). 
For neonates admitted to an NICU for at least 24 hours, 
probabilistic linkage was used to obtain data from the 
Canadian Neonatal Network, a sister network of  CPN in 
the Maternal Infant Care Network. For babies admitted to 
NICU for less than 24 hours, or not admitted to NICU, 
data were obtained directly from the neonatal hospital 
record. Bronchopulmonary dysplasia was recorded as 
present if  the infant required continuous supplemental 
oxygen at a postnatal gestational age of  36 weeks. 
Retinopathy of  prematurity was recorded as present if  
stage 3, 4, or 5 retinopathy of  prematurity was noted in 
the  discharge  summary.  Severe  brain  injury  was  defined 
as any of  intraventricular hemorrhage grade III or IV, 
ventricular enlargement with or without germinal matrix or 
intraventricular hemorrhage, parenchymal echodensities/
lucencies in the white or grey matter, periventricular 
leucomalacia, evidence of  diffuse brain lesions in the white 
matter (white matter injury) or multiple cysts in the white 
matter on ultrasound (cystic periventricular leucomalacia). 
Necrotizing enterocolitis was recorded as present if  
necrotizing enterocolitis, pneumatosis, or pneumatosis 
intestinalis, diagnosed by X-ray, at surgery, or at autopsy, 
Table 1. Maternal characteristics of women who delivered infants at 23+0 to 
23+6 weeks’ gestation (N = 248)
Characteristic
Maternal age, years* 30 .1 ± 6 .3 
30 [25 .8 to 34]
Parity
Nulliparous 53 .6% (133/248)
Parous 46 .4% (115/248)
Multiple pregnancy 18 .6% (46/247)
Pre-pregnancy weight, kg (n =128 ) 71 .9 ± 17 .7 
68 [58 to 81 .7]
Pre-pregnancy BMI (kg/m2) (n= 113) 26 .9 ± 6 .67 
25 [22 .3 to 31]
Underweight (BMI < 20 .0 kg/m2) 15 .9% (18/113)
Normal weight (BMI 20 .0 to 24 .9 kg/m2) 35 .4% (40/113)
Overweight (BMI 25 .0 to 29 .9 kg/m2) 20 .4% (23/113)
Obese (BMI > 30 .0 kg/m2) 28 .3% (32/113)
Ethnicity (n = 158 )
Caucasian 62 .0% (98/158)
Asian or Indo-Canadian 4 .4% (7/158)
African-Canadian 13 .3% (21/158)
Aboriginal 3 .2% (5/158)
Other 17 .1% (27/158)
Socioeconomic status (n = 219)† $67 968 ± $14 916 
$65 243 [$56 089 to $77 216]
Past obstetric history (parous women) (n = 115 )
Previous preterm birth < 37 weeks 33 .0% (38/115)
Previous preterm birth < 34 weeks 23 .5% (27/115)
Previous second trimester dilatation and evacuation 3 .5% (4/115)
Previous stillbirth 11 .3% (13/115)
Pre-existing medical conditions
Pre-existing hypertension 4 .0% (10/248)
Uterine structural abnormality 4 .8% (12/248)
Results are mean ± standard deviation, % (n), or median [quartiles]
*Maternal age at estimated due date
†Expressed as median neighbourhood income levels, derived from postal codes and census enumerator 
data obtained from Statistics Canada
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was recorded in the discharge summary. Neonatal sepsis 
was defined as having a positive blood or cerebrospinal fluid 
culture. Major congenital anomaly was recorded as present 
if  the neonatal chart indicated a confirmed anomaly.
Maternal morbidity included placental abruption, 
intensive care unit admission, receipt of  blood products, 
chorioamnionitis, and infection. Placental abruption was 
diagnosed clinically by the presence of  abdominal pain or 
uterine contractions with vaginal bleeding or intrauterine 
death. Chorioamnionitis was diagnosed clinically (for 
example, by the presence of  fetal tachycardia and abdominal 
tenderness with or without fever), by placental pathology 
(on the pathology report), or by culture of  the maternal 
genital tract, placenta, or blood showing growth of  Gram-
negative bacteria or anaerobes. Infection included sepsis 
(definite evidence of  infection with a systemic response to 
infection such as lactic acidosis, oliguria, or acute alteration 
in mental status) or endometritis (as indicated in the 
medical chart clinically or in the pathology report).
Descriptive statistics were calculated for maternal 
characteristics, obstetric complications, obstetric 
interventions, and maternal and perinatal outcomes. 
Categorical data were described as n (%) and continuous 
data as mean (standard deviation) or median (interquartile 
range), as appropriate. Two subgroup analyses were 
performed:  in  the  first,  antepartum  stillbirths  were 
excluded, and in the second antepartum stillbirths were 
excluded and only women who delivered at centres that 
offered fetal heart rate monitoring at 23 weeks’ gestation 
(according to a survey of  participating centres) and their 
infants were included.
The study was approved by the research ethics committees 
at each of  the participating centres.
RESULTS
The tertiary centres in the study included all geographic 
regions (6 Western centres, 8 Ontario/Quebec centres, 
2 Atlantic centres), with annual delivery rates of  ≥ 5000 
deliveries/year in six centres, 4000 to 4999 deliveries/
year  in two centres, 3000 to 3999 deliveries/year  in five 
centres, and 2000 to 2999 deliveries/year in three centres. 
A total of  248 women and 287 infants were included in 
this study. The maternal characteristics of  these women 
are  summarized  in  Table  1.  Almost  one  in  five  had 
multiple pregnancies, and approximately one half  were 
nulliparous. Of  those with BMI recorded, one quarter 
were obese. Of  parous women, one third had a history of  
preterm birth, and over 10% had a history of  a previous 
stillbirth.
The obstetric complications and interventions in these 
women are summarized in Table 2. Approximately one 
in six women smoked during their pregnancy, 2.9% used 
alcohol, and 3.7% used illicit drugs. The most common 
indication for inclusion that occurred either before or during 
admission was preterm premature ruptured membranes 
(41.1%); this was followed by preterm labour (38.7%), 
prolapsing membranes or cervical dilatation (23.8%), and 
antepartum hemorrhage (23.4%). Approximately one third 
of  women received antenatal corticosteroids for fetal lung 
maturation (34.3%), approximately one quarter received 
a tocolytic agent (23.8%), and 72.2% received antibiotics. 
Cervical cerclage placement occurred in 14.9% of  women. 
Of  the 85 women who received corticosteroids, 18 (21.1%) 
received them at another institution.
Maternal outcomes of  these women are presented in 
Table 3. The mean time from admission to delivery was 
two days, with 35.5% of  women delivering on the day of  
admission. Approximately 10% of  women delivered by 
Caesarean section. At least one serious maternal outcome 
Table 2. Obstetric complications and interventions of 
women who delivered infants at 23+0 to 23+6 weeks’ 
gestation (N = 248)
Complication
Smoking during pregnancy 17 .3% (42/243)
Alcohol use during pregnancy 2 .9% (7/243)
Illicit drug use during pregnancy 3 .7% (9/243)
Polyhydramnios 2 .9% (6/207)
Indicator conditions (occurrence any time)
Preterm labour on enrolment 38 .7% (96/248)
Short cervix* 10 .1% (25/248)
Prolapsing membranes† 23 .8% (59/248)
PPROM 41 .1% (102/248)
IUGR 2 .8% (7/248)
Gestational hypertension 5 .2% (13/248)
APH 23 .4% (58/248)
Interventions/investigations
Fetal fibronectin testing 0 .9% (1/116)
Corticosteroids for fetal lung maturation 34 .3% (85/248)
Tocolytic use 23 .8% (59/248)
Antibiotic use 72 .2% (179/248)
Cerclage placement 14 .9% (37/248)
Maternal transfer from another hospital 52 .0% (128/246)
Results are % (n)
*Short cervix: cervical shortening < 2 .0 cm by endovaginal ultrasound 
without regular contractions
†Prolapsing membranes: prolapsing membranes at or beyond the external 
as visualized on speculum examination, or any cervical dilatation of 
external os by endovaginal ultrasound, without regular contractions
PPROM: preterm premature rupture of membranes; IUGR: intrauterine 
growth restriction; APH: antepartum hemorrhage
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occurred in 40.3% of  women; the most common of  
these was chorioamnionitis (38.6%), followed by blood 
product transfusion (4.5%). One woman required ICU 
admission, and there were no maternal deaths. Of  the 
91 cases of  chorioamnionitis, 32 (35.2%) were based on 
clinical  findings,  55  (60.4%)  on  placental  pathology,  and 
four (4.4%) on a positive culture. The maternal outcomes 
of  the two subgroups were similar to the overall group, 
except that the Caesarean section rate was 22.0% in centres 
that indicated they offered fetal heart rate monitoring at 23 
weeks’ gestation (excluding antepartum stillbirths).
The outcomes for all infants are summarized in Figure 1. 
A total of  108 infants were admitted to NICU, but 
outcomes for 39 of  these infants were not known because 
they were transferred to NICUs in pediatric hospitals that 
were not participating in CPN. Of  all infants with known 
outcomes (N = 248), 23.3% (67/287) were stillborn and 
62.9% (156/248) had a neonatal death; 71.8% (112/156) 
of  neonatal deaths occurred before admission to NICU. 
Of  all infants with a known outcome, only 10.1% (25/248) 
survived to be discharged from NICU. All survivors had 
at least one serious form of  neonatal morbidity. The 
temporal trends in outcomes of  infants during the time 
period of  the study are shown in Figure 2. There were no 
significant differences in these outcomes over time (using 
Mann-Kendall test for trend). Details of  the perinatal 
outcomes are shown in Table 4. Of  all babies surviving 
to discharge (n = 25), approximately two thirds had 
bronchopulmonary dysplasia, over 50% had retinopathy 
of  prematurity, and 44% had severe brain injury. The 
perinatal outcomes of  the two subgroups were similar 
to the entire group, including similar rates of  survival 
to discharge (25/232 [10.8%] in the subgroup excluding 
antepartum stillbirths and 5/39 [12.8%] in the subgroup 
excluding antepartum stillbirths and including infants 
born in centres that offered fetal heart rate monitoring at 
23 weeks’ gestation).
DISCUSSION
Previous research on extreme preterm birth has focused 
on perinatal outcomes and not maternal outcomes.3–45 
We found a high rate of  chorioamnionitis in our study 
Table 3. Maternal outcomes of women who delivered infants at 23+0 to 23+6 weeks’ gestation 
 
 
 
 
Outcome
 
 
 
All women 
N = 248
 
Excluding women  
with antepartum  
stillbirth 
n = 234
Women delivering at centres 
that offer fetal monitoring at  
23 weeks’ gestation 
(excluding women with 
antepartum stillbirth) n = 50
Gestational age at enrolment, week 23 .2 ± 0 .4 
23 .2 [23 to 23 .6]
23 .2 ± 0 .4 
23 .1 [23 .0 to 23 .6]
23 .2 ± 0 .4 
23 .2 [23 .0 to 23 .6]
Gestational age at delivery, week 23 .5 ± 0 .3  
23 .6 [23 .1 to 23 .7]
23 .5 ± 0 .4 
23 .4 [23 .1 to 23 .7]
23 .5 ± 0 .3  
23 .6 [23 .2 to 23 .7]
Latency from enrolment to delivery, days 2 .0 ± 2 .5 
1 [0 to 3]
1 .8 ± 2 .4 
1 [0 to 3]
1 .8 ± 2 .5 
1 [0 to 2 .8]
Delivery on day of admission 35 .5% (88/248) 36 .3% (85/234) 38 .0% (19/50)
Caesarean section 10 .5% (26/248) 10 .7% (25/234) 22 .0% (11/50)
Abruption 6 .5% (16/247) 6 .4% (15/233) 10 .0% (5/50)
Serious maternal outcome 40 .3% (100/248) 41 .0% (96/234) 42 .0% (21/50)
1 serious outcome 37 .5% (93/248) 38 .0% (89/234) 38 .0% (19/50)
> 1 serious outcome 2 .8% (7/248) 3 .0% (7/234) 4 .0% (2/50)
Chorioamnionitis 38 .6% (91/236) 39 .0% 87/223) 45 .7% (21/46)
Blood product transfusion 4 .5% (11/247) 4 .3% (10/223) 4 .0% (2/50)
ICU admission 0 .4% (1/247) 0 .4% (1/233) 0% (0/50)
Death 0% (0/247) 0% (0/233) 0% (0/50)
Severe maternal morbidity
Infection 0% (0/247) 0% (0/233) 0% (0/50)
Respiratory complication 1 .2% (3/248) 1 .3% (3/234) 0% (0/50)
Hematologic complication 0 .4% (1/248) 0 .4% (1/234) 0% (0/50)
Other* 0 .8% (2/248) 0 .9% (2/234) 0% (0/50)
Results are % (n), mean ± standard deviation, or median [quartiles]
*Other = neurologic, cardiac, renal, hepatic
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Figure 1. Outcomes of all infants born at 23 weeks’ gestation
Figure 2. Temporal trends of neonatal outcomes by year of delivery
LB_NICU: live birth admitted to NICU; LB_nonNICU: live birth not admitted to NICU; SB: stillbirth
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cohort, based either on clinical diagnosis or on pathologic 
findings. In addition, we identified other serious maternal 
outcomes including blood product transfusion, respiratory 
complications, and ICU admission. It is important to 
recognize that these extreme preterm deliveries can result 
in  significant  maternal  morbidity  as  well  as  perinatal 
morbidity and mortality. The rate of  maternal morbidity 
may vary by the indication for admission; however, sample 
sizes for each indication were not large enough to allow 
comparison of  maternal morbidity by indication. The 
Caesarean section rate of  10.8% may seem lower than 
expected,  but  likely  reflects  a  decision  by  some  women 
and health care providers not to intervene. When only 
centres that offered fetal heart rate monitoring at 23 weeks’ 
gestation were included (and antepartum stillbirths were 
excluded), the Caesarean section rate increased to 22.0%, 
representing a higher rate of  intrapartum intervention.
We found a high perinatal mortality rate in infants born 
at 23 weeks’ gestation, with only 10.1% of  all infants 
with known outcomes surviving to discharge. There 
were similar survival rates for the subgroups. The rate of  
survival was 10.8% (25/232) when antepartum stillbirths 
were excluded and 12.8% (5/39) in centres that offered 
fetal heart rate monitoring at 23 weeks’ gestation. Previous 
studies have noted a wide range of  survival rates for all 
births (including stillbirths) at this gestation, ranging 
from 0% to 37%.5–7,9–12,14,17–19,36,37 Some studies present 
survival rates for live births only, ranging from 0% to 
53%.5,7,10,11,14,16–18,20,36,37,47 Other studies include only infants 
admitted to the NICU, with survival rates ranging from 
0% to 66%.4,9,11–15,17,18,20,21,23,24,34 Previous Canadian studies 
that did not include stillbirth noted survival rates in infants 
admitted to the NICU of  35.2% to 41.7%.4,15,24 The survival 
rate was lower in our study. We included infants delivering 
at 23 weeks’ gestation in participating centres, including 
stillbirths and neonatal deaths before admission to NICU, 
thus reducing selection bias. Different centres may have 
different resources and criteria for admission to NICU. In 
Table 4. Interventions and outcomes of infants born 23+0 to 23+6 weeks’ gestation (N = 287)
 
 
 
 
Outcome
 
 
 
All infants 
N = 287
Excluding 
infants with 
antepartum  
stillbirth  
n = 271
Infants delivering at centres that 
offer fetal monitoring at 23 weeks’ 
gestation (excluding infants with 
antepartum stillbirth)  
n = 54
Caesarean section 10 .8% (31/287) 11 .1% (30/271) 20 .4% (11/54)
Male 52 .3% (150/287) 50 .9% (138/271) 57 .4% (31/54)
Live births 79 .5% (221/287) 81 .2% (220/271) 87 .0% (47/54)
Perinatal mortality* 89 .9% (223/248) 89 .2% (207/232) 87 .2% (34/39)
Stillbirth 23 .3% (67/287) 18 .8% (51/271) 13 .0% (7/54)
Neonatal death* 62 .9% (156/248) 67 .2% (156/232) 69 .2% (27/39)
Perinatal mortality or severe morbidity* 100% (248/248) 100% (232/232) 100% (39/39)
Perinatal mortality or severe brain injury* 94 .4% (234/248) 94 .0% (218/232) 92 .3% (36/39)
Congenital anomaly 9 .3% (23/247) 9 .1% (21/231) 7 .9% (3/38)
Birthweight, grams 577 ± 101 581 ± 95 608 ± 84
Small for gestational age*
< 10% 11 .2% (32/287) 9 .2% (25/271) 1 .9% (1/54)
< 3% 4 .5% (13/287) 3 .3% (9/271) 0% (0/54)
NICU admission* 37 .6% (108/287) 39 .9% (108/271) 46 .3% (25/54)
Perinatal morbidities for survivors 100% (25/25) 100% (25/25) 100% (5/5)
Bronchopulmonary dysplasia 64 .0% (16/25) 64 .0% (16/25) 60 .0% (3/5)
Retinopathy of prematurity 58 .3% (14/24) 58 .3% (14/24) 40 .0% (2/5)
Severe brain injury 44 .0% (11/25) 44 .0% (11/25) 40 .0% (2/5)
Necrotizing enterocolitis 24 .0% (6/25) 24 .0% (6/25) 20 .0% (1/5)
Neonatal sepsis 44 .0% (11/25) 44 .0% (11/25) 80 .0% (4/5)
SNAPII score 11 .8 ± 18 .7 
0 [0 to 21 .8]
11 .8 ± 18 .7 
0 [0 to 21 .8]
9 .5 ± 15 .8 
0 [0 to 19 .5]
Results are % (n), mean + standard deviation, median [quartiles]
*Includes all infants with follow up to death or hospital discharge
SNAPII: Score for Neonatal Acute Physiology 2nd version
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the current study, 23.0% of  all infants were stillborn and 
39.4% died before admission to NICU. If  we had included 
only infants admitted to the NICU with follow-up to 
discharge or death in NICU, the survival rate would have 
been 36.2% (25/69), thus overestimating the true perinatal 
survival rate.5,45,48,49 The information on perinatal survival 
from our study allows us to counsel women admitted at 
23 weeks’ gestation more accurately regarding all possible 
outcomes of  delivery in this gestational week.
A very high morbidity rate was noted among infants surviving 
to discharge, and all survivors had at least one serious morbid 
condition. This high rate is similar to those in other reports, 
which describe rates of  survival without morbidity ranging 
from 7% to 28%.3,4,9,14,15,24,42 Previous Canadian research has 
also noted rates of  morbidity in survivors after admission 
to the NICU of  71.6% to 92.9%.4,15,24 In the current 
study, morbidity included bronchopulmonary dysplasia, 
retinopathy of  prematurity, severe brain injury, necrotizing 
enterocolitis, and sepsis. Some other studies did not include 
sepsis among morbidities.4,15,24 Even excluding sepsis, the 
rate of  morbidity in survivors was 96.0% for infants with 
known outcomes (24/25).
We found that approximately one third of  women in our 
cohort received corticosteroids for fetal lung maturation. 
No randomized trials have evaluated corticosteroids at 
this gestational age,50 although some cohort studies have 
suggested that they may be of  benefit in reducing mortality 
and possibly intraventricular hemorrhage.9,28,51–54 Further 
research is needed to determine if  interventions such as 
administration of  corticosteroids in this population does 
indeed reduce perinatal morbidity or mortality.
The mean latency from admission to delivery in the study 
cohort was only two days. This may be partly explained by 
the inclusion criteria of  the CPN. The earliest gestational 
age at admission was 22 weeks. Thus women admitted 
before 22 weeks with obstetric complications were not 
included in the study. Also contributing to the short latency 
period may be the high rate of  infection, as evidenced by 
a high rate of  maternal chorioamnionitis. Additionally, the 
short  latency may  reflect  the  fact  that  patients  or  health 
care providers may not recognize early signs or symptoms 
of  obstetric complications (such as preterm labour) that 
result in periviable birth, or that these early signs and 
symptoms are not obvious or evident.
Limitations of  previous studies include reporting of  
outcomes by birth weight and not by gestational age.40,43,44,55 
Some studies have reported data from over two decades 
ago,6,40,42,55 and survival has improved during this time 
period.5,56  Older  data  may  therefore  not  reflect  current 
rates of  morbidity and mortality. In addition, previously 
published studies evaluating populations without universal 
access to health care could potentially have different 
outcomes as a result of  this lack of  access.
Our study has a number of  limitations. The CPN cohort 
does not include women admitted to hospital for reasons 
other than one of  the indicator conditions, nor does it 
include women who were admitted before 22 weeks’ 
gestation but who delivered at 23 weeks. Our study cohort 
likely included infants for whom a decision was made not 
to resuscitate, but planned palliative care was not a variable 
recorded in the database. The wishes of  parents regarding 
interventions for infants delivered at 23 weeks’ gestation 
may range from no intervention at all (with comfort care 
only) to assessment at delivery and resuscitation if  the 
baby appears “vigorous,” and to planned resuscitation at 
delivery.45 The wishes of  parents may also change during 
the course from admission to delivery.45 It is not known 
how many women were not transferred to a tertiary centre 
because active neonatal resuscitation would not be offered 
and who consequently delivered in their community centre.
Active management of  extremely preterm infants increases 
survival.5,36,45,48 A survey of  participating CPN centres from 
September 2011 to January 2012 noted variation among 
centres regarding the lowest gestational age at which 
fetal monitoring begins (at 23 weeks in 5 centres, and at 
24 weeks in 9 centres), the lowest estimated fetal weight 
at which interventions for signs of  fetal compromise are 
considered (at 400 g in 1 centre, at 500 g in 11 centres, 
and at 600 g in 2 centres), and actual birth weight at which 
active resuscitation occurs (at 400 g in 2 centres, and at 
500 g in 11 centres).
Outcome data are missing for a number of  infants in our 
study. A total of  39 infants (13.6% of  the perinatal cohort) 
were transferred to NICUs that were not participating in 
CPN, and follow-up data are therefore not available for 
these infants. Because our study included only tertiary 
care perinatal centres, our findings may not be applicable 
to deliveries in other Canadian centres. Unfortunately, 
because of  the absence of  a shared national data set, we do 
not have information about the outcomes of  mothers and 
babies delivering in non-CPN centres. Some demographic 
data, such as maternal BMI and ethnicity, were not available 
for all mothers and infants. We did not stratify levels of  
morbidity, and so cannot comment on the severity of  
morbidity. We did not perform subgroup analyses for 
perinatal outcomes by indicator condition because of  
small sample sizes. It might be expected that morbidity 
and mortality would be higher in some conditions, such 
as severe intrauterine growth restriction or preterm pre-
222  l  MARCH JOGC MARS 2015
OBSTETRICS
labour rupture of  membranes with chorioamnionitis. 
We do not have data for infants after discharge and 
therefore cannot comment on long-term outcomes such 
as neurodevelopmental impairment. We did not evaluate 
regional or between-centre differences in maternal and 
perinatal morbidities or perinatal mortality. The rates of  
some maternal outcomes such as chorioamnionitis may 
vary between centres because of  differences in diagnosis 
(clinical versus pathological).
A strength of  our study is that all perinatal outcomes, 
including stillbirth and neonatal death, were evaluated, 
providing a more accurate reflection of  perinatal outcomes 
and reducing selection bias. In addition to perinatal 
outcomes, our study also evaluated maternal outcomes, and 
included the majority (16 of  23) of  tertiary care perinatal 
centres in Canada with recent data (from 2005 to 2011).
CONCLUSION
Pregnant women delivering at 23 weeks’ gestation are at 
risk of  morbidity. Their infants have high rates of  serious 
morbidity and mortality, with only 10.1% in this cohort 
surviving to discharge from NICU and all survivors having 
one or more forms of  neonatal morbidity. This low rate of  
survival may reflect a decision by some women and health 
care providers not to intervene, and does not necessarily 
reflect perinatal survival if  the decision is made to provide 
active intrapartum intervention and aggressive resuscitation. 
This information can be used to counsel women and their 
families and can help in making decisions regarding the 
care and management of  these women. It is also important 
for counselling to be individualized, based on each centre’s 
experience. Further research is needed to identify strategies 
and management that will not only increase survival, but 
also reduce morbidities in these extremely low gestational 
age infants and reduce maternal morbidity.
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APPENDIX 
CANADIAN PERINATAL NETWORK (CPN) COLLABORATIVE GROUP
